Genentech to Acquire CDK Inhibitors to treat breast cancer

Regor Pharmaceuticals (USA), a branch of Regor Therapeutics Group, a biotech company in the clinical testing phase, has agreed to a deal where Genentech, part of the Roche Group, will buy a set of advanced CDK inhibitors from Regor to treat breast...

Venus Remedies Receives Market Authorisations for two cancer drugs

Venus Remedies Ltd, a leading pharmaceutical company, announced that it has obtained approvals to market two important oncology medications (carboplatin and bortezomib) in Morocco and the Philippines. "These approvals are pivotal in our...

Boston Scientific Bags PDMA Nod in Japan for FARAPULSE PFA System

Boston Scientific Corporation, a leading company in the field of global medical technology, stated that it has been granted approval by the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan for the FARAPULSE Pulsed Field Ablation (PFA)...

Dr Reddy's Funnels USD 620 Million in Switzerland subsidiary

Drug manufacturer Dr Reddy's Laboratories Ltd has invested $620 million into its wholly-owned branch, Dr Reddy’s Laboratories SA, Switzerland (DRL SA). This investment is consistent with the company's previous board-approved decision to invest up...

BFI Join Hands with CSIR- CDRI to advance biomedical innovation

CSIR-Central Drug Research Institute (CDRI), an esteemed research institute in the field of biomedicine, has revealed a partnership with Blockchain For Impact (BFI) to participate in the BFI-BIOME Virtual Network Programme. This partnership will...

US FDA Nods AstraZeneca's Tagrisso for patients with unresectable

Tagrisso (osimertinib) from AstraZeneca has been given the approval in the US to treat adult patients with unresectable, Stage III EGFRm NSCLC who have not seen their disease worsen after platinum-based CRT. Tagrisso is approved for individuals...

WHO issues guidance to boost clinical trials, speed health innovation

The World Health Organization (WHO) issued guidance on how to enhance the organization and supervision of clinical trials in nations with diverse income levels. This guidance seeks to enhance country-led R&D ecosystems in order to progress health...

AskBio Partners with Belief BioMed to advance gene therapies

Sklepios BioPharmaceutical (AskBio), has formed a strategic alliance with Belief BioMed in China to further the progress of innovative gene therapies. The goal of the collaboration is to take advantage of the experience of both companies in gene...

MediBuddy and Philips Join Hands to bring advanced heart health tracking

MediBuddy, the biggest digital healthcare platform in India, has partnered with Philips, a global leader in health technology, to transform preventive healthcare in India. For World Heart Day on September 29, the collaboration will provide heart...

MedGenome and Twist Bioscience Team up to diagnose rare diseases

MedGenome, a prominent worldwide genomics-focused diagnostics and research services company, is joining forces with Twist Bioscience, a fast-growing synthetic biology and genomics company in the US, to create the HOPE for Rare Diseases Programme...

© 2024 India Pharma Outlook. All Rights Reserved.